Human medicines European public assessment report (EPAR): Filgrastim Hexal, filgrastim, Date of authorisation: 06/02/2009, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Filgrastim Hexal, filgrastim, Date of authorisation: 06/02/2009, Revision: 24, Status: Authorised

Metadata
Provider: 
European Medicines AgencyEuropean Medicines Agency
URL: 
https://www.ema.europa.eu/en/medicines/human/EPAR/filgrastim-hexalhttps://www.ema.europa.eu/en/medicines/human/EPAR/filgrastim-hexal
Retrieved on: 
Tuesday, January 2, 2024
Information
Tags: 
Medical Subject Headings, Marketing, Febrile neutropenia, European Commission, INN, Fever, Risk, HIV/AIDS, Bone marrow, Allergy, ATC, Hematopoietic stem cell transplantation, Pain, International, European, Blood, Language, Infection, DNA, Incidence, ANC, Neutrophil, DSM-IV codes, HIV, Syndrome, Select, Committee, Patient, Cell, Safety, Anatomy, Medicine, Malignancy, IIA, History, CHMP, Leukemia, Skin, Acute leukemia, Vaccine
Geotags: 
EUROPEAN UNION, EU
Summary
Key Points: 


Human medicines European public assessment report (EPAR): Filgrastim Hexal, filgrastim, Date of authorisation: 06/02/2009, Revision: 24, Status: Authorised

Copyright: 
2024 European Medicines Agency. All Rights Reserved.